96 related articles for article (PubMed ID: 2288824)
1. Further development of a morphine hydrogel suppository.
Cole L; Hanning CD; Robertson S; Quinn K
Br J Clin Pharmacol; 1990 Dec; 30(6):781-6. PubMed ID: 2288824
[TBL] [Abstract][Full Text] [Related]
2. The morphine hydrogel suppository. A new sustained release rectal preparation.
Hanning CD; Vickers AP; Smith G; Graham NB; McNeil ME
Br J Anaesth; 1988 Aug; 61(2):221-7. PubMed ID: 3415895
[TBL] [Abstract][Full Text] [Related]
3. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of morphine in rabbits after rectal administration of suppository containing controlled release morphine tablet.
Kanamoto I; Zheng NX; Ueno M; Koizumi T; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1883-6. PubMed ID: 1394709
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of two novel rectal controlled-release morphine formulations.
Babul N; Darke AC; Anslow JA; Krishnamurthy TN
J Pain Symptom Manage; 1992 Oct; 7(7):400-5. PubMed ID: 1484193
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
Ellison NM; Lewis GO
Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
[TBL] [Abstract][Full Text] [Related]
7. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
8. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
Gourlay GK
Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
[TBL] [Abstract][Full Text] [Related]
9. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
10. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition.
Kawashima S; Inoue Y; Shimeno T; Fujiwara H
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):498-505. PubMed ID: 2337965
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of a morphine suppository given rectally and in a colostomy.
Højsted J; Rubeck-Petersen K; Rask H; Bigler D; Broen Christensen C
Eur J Clin Pharmacol; 1990; 39(1):49-50. PubMed ID: 2276388
[TBL] [Abstract][Full Text] [Related]
12. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
[TBL] [Abstract][Full Text] [Related]
13. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.
Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y
Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.
Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
J Clin Oncol; 1995 Jun; 13(6):1520-7. PubMed ID: 7751901
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
[TBL] [Abstract][Full Text] [Related]
16. [A patient with hepatoma and hepatic cirrhosis showing abnormally high blood morphine concentration after periodical suppository administration].
Kameue T; Matoba M; Ogawa H
Masui; 1994 Jan; 43(1):126-9. PubMed ID: 8309046
[TBL] [Abstract][Full Text] [Related]
17. [Analgesic activity of morphine suppository in rats].
Kita A; Nakamura H; Kadokawa T; Tan T
Yakugaku Zasshi; 1990 May; 110(5):349-53. PubMed ID: 2376826
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.
Vater M; Smith G; Aherne GW; Aitkenhead AR
Br J Anaesth; 1984 Aug; 56(8):821-7. PubMed ID: 6743446
[TBL] [Abstract][Full Text] [Related]
19. The influence of rectal cisapride on morphine-induced gastric stasis.
Kluger MT; Plummer JL; Owen H
Anaesth Intensive Care; 1991 Aug; 19(3):346-50. PubMed ID: 1767901
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of eudragit gels. V. Rectal gel preparations for sustained release and avoidance of first-pass metabolism of lidocaine.
Kim NS; Umejima H; Ito T; Uchida T; Goto S
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2800-4. PubMed ID: 1464113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
